Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
5,300
Employees5,300
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
5,300
Employees5,300

GMED Key Statistics

Market cap
8.31B
Market cap8.31B
Price-Earnings ratio
23.80
Price-Earnings ratio23.80
Dividend yield
Dividend yield
Average volume
1.32M
Average volume1.32M
High today
$61.99
High today$61.99
Low today
$60.26
Low today$60.26
Open price
$61.51
Open price$61.51
Volume
1.63M
Volume1.63M
52 Week high
$94.93
52 Week high$94.93
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

The current Globus Medical(GMED) stock price is $61.99, with a market capitalization of 8.31B. The stock trades at a price-to-earnings (P/E) ratio of 23.80.

On 2025-11-05, Globus Medical(GMED) stock traded between a low of $60.26 and a high of $61.99. Shares are currently priced at $61.99, which is +2.9% above the low and 0.0% below the high.

Globus Medical(GMED) shares are trading with a volume of 1.63M, against a daily average of 1.32M.

During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $94.93 at its peak.

During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $94.93 at its peak.

GMED News

Nasdaq 5d
Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3

The third-quarter 2025 earnings season is underway, with several healthcare companies already reporting their results. Early trends reveal multiple growth catal...

Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3
Simply Wall St 6d
Globus Medical: Examining Valuation as Share Price Recovers but Remains Below Analyst Targets

Globus Medical (GMED) shares have seen some swings lately, as investors assess how the company's performance stacks up against the broader healthcare sector. Re...

Globus Medical: Examining Valuation as Share Price Recovers but Remains Below Analyst Targets

Analyst ratings

60%

of 15 ratings
Buy
60%
Hold
40%
Sell
0%

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.